Report on 4 cases with decreased recovery due to neutralizing antibodies specific for PEGylated recombinant factor VIII.

Autor: Hillarp A; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway; Department of Translational Medicine, Lund University, Lund, Sweden., Holme PA; Department of Haematology, Oslo University Hospital, Oslo, Norway; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Wåland EP; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway., Le MS; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway., Henriksson CE; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Tjønnfjord GE; Department of Haematology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Måseide RJ; Department of Haematology, Oslo University Hospital, Oslo, Norway. Electronic address: ragmas@ous-hf.no.

Publikováno v: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2023 Oct; Vol. 21 (10), pp. 2771-2775. Date of Electronic Publication: 2023 Aug 03.